ECCO Position statement on the use of biosimilars for inflammatory bowel disease – An update

dc.contributor.author	Danese, S
dc.contributor.author	Fiorino, G
dc.contributor.author	Raine, T
dc.contributor.author	Ferrante, M
dc.contributor.author	Kemp, K
dc.contributor.author	Kierkus, J
dc.contributor.author	Lakatos, Péter László
dc.contributor.author	Mantzaris, G
dc.contributor.author	van der Woude, J
dc.contributor.author	Panes, J
dc.contributor.author	Peyrin-Biroulet, L
dc.date.accessioned	2021-09-17T10:32:53Z
dc.date.available	2021-09-17T10:32:53Z
dc.date.issued	2017
dc.identifier	85015798741
dc.identifier.citation	journalVolume=11;journalIssueNumber=1;journalTitle=JOURNAL OF CROHNS & COLITIS;pagerange=26-34;journalAbbreviatedTitle=J CROHNS COLITIS;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/7239
dc.identifier.uri	doi:10.1093/ecco-jcc/jjw198
dc.format.extent	26-34
dc.relation.ispartof	urn:issn:1873-9946
dc.title	ECCO Position statement on the use of biosimilars for inflammatory bowel disease – An update
dc.type	Journal Article
dc.date.updated	2019-07-16T11:40:22Z
dc.language.rfc3066	en
dc.rights.holder	NULL
dc.identifier.mtmt	3160158
dc.identifier.wos	000397066500003
dc.identifier.pubmed	27927718
dc.contributor.department	SE/AOK/K/I. Sz. Belgyógyászati Klinika
dc.contributor.institution	Semmelweis Egyetem